A review summarized potential mechanisms by which BRAF inhibitors can induce squamous cell carcinoma, including individual HRAS gene mutations and infections with human papillomavirus (HPV) or human polyomavirus (HPyV) (34). The gene discussed is HRAS; the disease is squamous cell carcinoma.